Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fetal liver transplants.

R P Gale1

  • 1Department of Medicine, UCLA School of Medicine 90024-1678.

Bone Marrow Transplantation
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Hematopoietic stem cells from second-trimester fetal liver can restore blood cell production and reduce graft-versus-host disease. These cells offer a promising source for gene modification and transplantation therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program.

Blood·2001
Same author

Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission.

Blood·2000
Same author

Decreased chronic lymphocytic leukemia incidence in Asians in Los Angeles County.

Leukemia research·2000
Same author

Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).

Blood·2000
Same author

T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities.

Blood·2000
Same author

Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia.

Blood·2000
Same journal

Transplant outcomes for patients with severe acquired aplastic anemia over the age of 40 using busulfan, fludarabine, reduced-dose cyclophosphamide, and anti-thymocyte globulin conditioning regimen.

Bone marrow transplantation·2026
Same journal

A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia.

Bone marrow transplantation·2026
Same journal

Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.

Bone marrow transplantation·2026
Same journal

Evaluation of a novel eHealth-facilitated, post HCT-integrated care model on implementation and rehospitalization: results from the Swiss SMILe hybrid-RCT.

Bone marrow transplantation·2026
Same journal

Impact of doublet post-transplant maintenance on outcomes in multiple myeloma: A propensity score matching analysis.

Bone marrow transplantation·2026
Same journal

A multimodal sexual health intervention among hematopoietic stem cell transplant recipients: mediating effects on quality of life and mood.

Bone marrow transplantation·2026
See all related articles

Area of Science:

  • Stem cell biology
  • Hematology
  • Transplantation immunology

Background:

  • Bone marrow failure necessitates hematopoietic stem cell transplantation.
  • Fetal liver stem cells offer potential advantages over other sources.
  • Graft-versus-host disease remains a significant challenge in transplantation.

Purpose of the Study:

  • To evaluate the efficacy of fetal liver-derived hematopoietic stem cells for transplantation.
  • To compare fetal liver stem cells with alternative stem cell sources.
  • To explore the potential of fetal liver stem cells for gene modification.

Main Methods:

  • Transplantation of fetal liver-derived hematopoietic stem cells in animal and human models.
  • Assessment of hematopoiesis restoration and graft-versus-host disease incidence.

Related Experiment Videos

  • Comparative analysis with bone marrow, umbilical cord, and adult blood stem cells.

    • Main Results:

    • Fetal liver stem cells successfully restored hematopoiesis in bone marrow failure models.
    • Reduced incidence of graft-versus-host disease observed with fetal liver stem cells.
    • Fetal liver stem cells demonstrated high purity and proliferative potential.

    Conclusions:

    • Second-trimester fetal liver stem cells are a viable and effective source for hematopoietic stem cell transplantation.
    • These cells present a reduced risk of graft-versus-host disease, enhancing transplant safety.
    • Their purity and proliferative capacity make them attractive candidates for gene therapy and further research.